Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
About this study
The study aspires to provide outcomes on surgery, quality of life and time-to-event outcomes following the development and validation of a standardised surgical assessment tool in a shared decision-making framework for patients with pre-invasive or invasive breast cancer with breast conservation.
- Condition
- Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Invasive, Breast Asymmetry
- Sponsor
- Uppsala University
Who can join
- Age
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 18 years
- Eligible sex: Female
- Study condition: Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Invasive, Breast Asymmetry
- Female aged above 18 years.
- Signed and dated written informed consent before the start of specific protocol procedures; oral consent for the participants of the quality control retrospective cohort study before accepting to partake a telephone interview.
- Patients with invasive breast cancer (IBC) or ductal cancer in situ (DCIS) or unclear lesions mandating surgical excision or benign lesions amenable for surgical resection with BCS.
- ECOG performance status 0-2.
Exclusion 3
- Life expectancy of less than 6 months
- Non candidate for breast conservation
- Inability to understand given information and give informed consent or undergo study procedures
Where
3 sites, 3 recruiting
Westmead Breast Cancer Institute
Sydney, Australia
Uppsala University Hospital
Uppsala, Sweden
Royal Marsden Hospital
London, United Kingdom
Contact
-
Andreas U Karakatsanis, MD, PhD
+46765864826 andreas.karakatsanis@uu.se
Potential match only. Final eligibility is determined by the study team.